Alliance Recovery Center
Conyers
SAMHSACARF
- Address
- 3430 Highway 20 SE, Conyers, GA, 30013
- Phone
- (770) 922-4482
- Insurance Accepted
- Medicaid · Medicare · Private Insurance · Self-Pay · Sliding Scale
- MAT Available
- Buprenorphine, Methadone
Outpatient
Outpatient Treatment Programs in Conyers, Georgia
4 outpatient programs in Conyers, Georgia provide ongoing counseling and support for people in early or sustained recovery. 2 programs accept Medicaid.
- Address
- 3430 GA-20, Conyers, GA, 30013
- Phone
- (770) 922-4482
- MAT Available
- Buprenorphine, Methadone
Outpatient
SAMHSA
- Address
- 930 Green Street SW, Conyers, GA, 30012
- Phone
- (770) 713-8580
- Insurance Accepted
- Self-Pay
Outpatient
View Point Health
Rockdale Center
SAMHSACARF
- Address
- 977 Taylor Street SW, Suite A, Conyers, GA, 30012
- Phone
- (678) 209-2411
- Insurance Accepted
- Medicaid · Medicare · Self-Pay · Sliding Scale
- MAT Available
- Methadone
Outpatient
Not sure which level of care is right?
Answer 7 short questions to find the treatment level that fits your situation.
Looking for sober housing while attending outpatient? View sober living homes in Conyers →
Frequently Asked Questions
What is outpatient addiction treatment?
Outpatient addiction treatment provides counseling, group therapy, and clinical support while you live at home. Sessions typically occur 1–3 times per week. Outpatient is best for people with mild-to-moderate substance use, a stable home environment, and strong social support.
Can I work while in outpatient treatment?
Yes — outpatient treatment is designed to fit around work, school, and family responsibilities. Many Georgia programs offer morning, afternoon, and evening scheduling. Your counselor will help you create a schedule that supports both recovery and daily life.
How long is outpatient treatment in Georgia?
Standard outpatient treatment typically lasts 3–6 months, though some people continue lower-frequency sessions for a year or more. Length depends on severity of use, co-occurring conditions, and clinical progress.